期刊
ACS NANO
卷 16, 期 4, 页码 6527-6540出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsnano.2c00893
关键词
RBC-derived nanocarriers; deformability; drug delivery; long circulation; tumor penetration
类别
资金
- National Natural Science Foundation of China [81973250, 82025032, 82104113]
- Natural Science Foundation of Shanghai [21ZR1475800]
- National Key R&D Program of China [2020YFE0201700]
- Science and Technology Commission of Shanghai Municipality [20431900100]
This study presents the construction of nanocarriers that can mimic the biological and physical properties of red blood cells (RBCs) at different life stages. The nanocarriers demonstrated high immunocompatibility and superior antitumor efficacy compared to conventional chemotherapy drugs. The ability of the nanocarriers to deform and penetrate tumor tissues highlights their potential for future bionic design of nanomedicines.
Despite considerable advancements in cell membrane-camouflaged nanocarriers to leverage natural cell functions, artificial nanocarriers that can accurately mimic both the biological and physical properties of cells are urgently needed. Herein, inspired by the important effect of the stiffness and deformability of natural red blood cells (RBCs) on their life span and flowing through narrow vessels, we report the construction of RBC membrane-camouflaged nanocarriers that can mimic RBCs at different life stages and study how the deformability of RBC-derived nanocarriers affects their biological behaviors. RBC membrane-coated elastic poly(ethylene glycol) diacrylate hydrogel nanoparticles (RBC-ENPs) simulating dynamic RBCs exhibited high immunocompatibility with minimum immunoglobulin adsorption in the surface protein corona, resulting in reduced opsonization in macrophages and ultralong circulation. Furthermore, RBC-ENPs can deform like RBCs and achieve excellent diffusion in tumor extracellular matrix, leading to improved multicellular spheroid penetration and tumor tissue accumulation. In mouse cancer models, doxorubicin-loaded RBC-ENPs demonstrated superior antitumor efficacy to the first-line chemotherapeutic drug PEGylated doxorubicin liposomes. Our work highlights that tuning the physical properties of cell membrane-derived nanocarriers may offer an alternative approach for the bionic design of nanomedicines in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据